Carozza, Jacqueline A.
Böhnert, Volker
Nguyen, Khanh C.
Skariah, Gemini
Shaw, Kelsey E.
Brown, Jenifer A.
Rafat, Marjan http://orcid.org/0000-0002-9444-4379
von Eyben, Rie
Graves, Edward E. http://orcid.org/0000-0003-4265-9041
Glenn, Jeffrey S.
Smith, Mark
Li, Lingyin http://orcid.org/0000-0003-4386-7926
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (DP2CA228044)
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH-18-1-0041, W81XWH-18-1-0041, W81XWH-18-1-0041)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI109662)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (F31CA239510, R01CA197136)
National Science Foundation (GRFP)
U.S. Department of Health & Human Services | National Institutes of Health (S10OD018208)
Article History
Received: 27 September 2019
Accepted: 15 January 2020
First Online: 24 February 2020
Competing interests
: M.S. and L.L. are scientific cofounders of Angarus Therapeutics, which has exclusive licensing rights to patent PCT/US2018/50018. J.A.C., V.B., K.E.S., M.S. and L.L. are inventors on patent PCT/US2018/50018.